Latest News Archive
Please select Category, Year, and then Month to display items
23 November 2022
|
Story André Damons
![]()
Prof Motlalepula Matsabisa, Professor and Director of Pharmacology, will play host to the various stakeholders to network and share knowledge on current developments in indigenous knowledge research and product development, biodiversity, innovation, and commercialisation of the IK-based research products. The Indigenous Knowledge System (IKS) for Health unit in the Department of Pharmacology within the UFS Faculty of Health Sciences was last year awarded an annual Technology Innovation Agency Platform (TIA) grant of R17 million for the next five years.
The research and teaching programme in the School of Clinical Medicine has since been rebranded and is now known as the African Medicines Innovation and Technology Development Platform (AMITD), which will strive to respond to community health needs and address industry research needs and challenges.
The indaba will showcase progress made by TIA and other entities in enriching the development and commercialisation of IK-based innovations. It will take place from 24 to 25 November 2022 in the Equitas Senate Hall at the UFS.
Prof Matsabisa is the chairperson of the World Health Organisation’s (WHO) Regional Expert Advisory Committee on Traditional Medicines for COVID-19. He is also a visiting professor at the Beijing University of Chinese Medicine (BUCM) in Beijing, China, and the Deputy President of the South African Society for Basic and Clinical Pharmacology.
CDS receives another international grant from the NIH
2015-12-11
 Dr Carla Sharp |
The Centre for Development Support (CDS) is partner to another international research grant from the National Institutes of Health (NIH) in the United States. The new project follows an earlier project funded by the NIH, which focused on the mental health of orphans and vulnerable children.
The new project is to focus on investigating possible improvements in the mental health and cognitive development of orphaned and vulnerable children aged between seven and eleven years, by means of improved community-based care in the Mangaung Township area in Bloemfontein. The project will stretch over three years and has a budget of approximately R10 million.
“We shall use the Mediational Intervention of Sensitizing Caregivers (MISC) approach and it will be applied by community-based organisations,” says Dr Deidre van Rooyen, Acting Director of the CDS.
MISC applied by caregivers has produced good results elsewhere in the world. “This is the first time MISC will be tested by community-based organisations,” says Prof Lochner Marais of the CDS, who is also the principal investigator in South Africa.
“In addition to working with four community-based organisations in Mangaung, Childline Free State will also be actively involved in the project,” Marais added.
The project is being conducted in collaboration with Dr Carla Sharp as principal investigator at the University of Houston, and Prof Michael Boivin (an international expert on MISC) at the Michigan State University. Dr Sharp was recently appointed visiting professor at the CDS.
“It is indeed a great privilege to be working with the CDS on yet another project,” Dr Sharp remarked, also noting that “the project is preliminary in nature and could evolve into a much bigger research project in future”.